PPCB Stock Summary and Trading Ideas (Propanc Biopharma | NASDAQ:PPCB)

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

What symbol and exchange does Propanc Biopharma shares trade?

Propanc Biopharma trades on the NASDAQ stock market under the symbol PPCB.

What is Propanc Biopharma stock price doing today?

As of June 16, 2026, PPCB stock price declined to $1.93 with 406,997 million shares trading.

What is Propanc Biopharma's Beta?

PPCB has a beta of 2.20, meaning it tends to be more sensitive to market movements. PPCB has a correlation of 0.06 to the broad based SPY ETF.

How much is Propanc Biopharma worth?

PPCB has a market cap of $4.40 million. This is considered a Sub-Micro Cap stock.

What are the support and resistance levels for Propanc Biopharma (PPCB)?

PPCB support price is $1.91 and resistance is $2.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PPCB shares will trade within this expected range on the day.